Work

A phase I trial of liposomal doxorubicin (D), bevacizumab (A), and temsirolimus (T) in advanced malignancy

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e13508

Authors: J. W. Moroney, R. L. Coleman, D. S. Hong, J. J. Wheler, C. Ng, D. C. Bodurka, G. Falchook, A. Naing, T. Helgason, R. Kurzrock

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2223738955

Cites:

Cited by: 2

Related to: 10